Navigation Links
Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC


RESEARCH TRIANGLE PARK, NC, Dec. 10 /PRNewswire-FirstCall/ - Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry is pleased to announce the opening of its new U.S. headquarters and analytical lab facilities in the vicinity of Research Triangle Park (RTP), North Carolina.

Established nearly five decades ago on 7,000 acres of land, Research Triangle Park has evolved into an international hub for high-tech, award winning research and development. Patheon joins over 170 other companies currently headquartered in this region of North Carolina.

In addition to the new U.S. headquarters facility, Patheon has opened a new pharmaceutical development laboratory in RTP. This laboratory will support Patheon's current U.S.-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services.

Wes Wheeler, Chief Executive Officer and President of Patheon Inc., stated: "North Carolina is a rapidly growing center for the pharmaceutical industry, which now boasts 334 biotechnology-related companies. It is a pro-business community which combines attractive corporate incentives with a high quality of life for our employees. We are delighted to open our new U.S. headquarters and our new laboratory here, in the vicinity of Research Triangle Park."

To mark this special occasion, Patheon will host state and local officials, customers and employees at a ribbon cutting ceremony on December 10, 2008 at their new U.S. headquarters, located in the Imperial Center at 4721 Emperor Boulevard, Durham, NC. The laboratory facility is a few miles away in Research Triangle Park.

North Carolina Secretary of Commerce Jim Fain stated, "We are delighted to welcome Patheon to North Carolina. The addition of such a well-respected company can only enhance our state's reputation as a world leader in the biopharmaceutical sector and we look forward to Patheon being a member of our corporate community."


Patheon Inc. (TSX: PTI; is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, Liquid-Filled Hard Capsules and a variety of modified release technologies.

Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic(TM) programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated network strives to ensure that customer products can be launched with confidence globally.

Caution Concerning Forward-Looking Statements

This news release may contain forward-looking statements which reflect management's expectations regarding the Company's future growth of operations, performance (both operational and financial) and business prospects and opportunities. These statements are made in the context of the risks and uncertainties that are outlined in the Company's public documents, which can be accessed on our website at or on SEDAR at

SOURCE Patheon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
2. An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region
3. Concentra Opens On-Site Medical Unit at World Trade Center Site
4. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
5. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
6. OrthoSynetics(TM) Opens New Data Center, Colocation Facility
7. AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove, Illinois
8. Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff
9. UCI Medical Affiliates Inc. Opens a New Doctors Care Center in Anderson
10. ARx(TM) Opens New Pharmaceutical Manufacturing Facility
11. SalesForce4Hire Opens New Office
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
Breaking Medicine Technology: